4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cyclerion Therapeutics, Inc. (CYCN) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 1 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-12-31, CYCN reported $2M in revenue and ($4M) in net income.
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.
Interactive charts & full statements → Open the CYCN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($4M) | ($10M) | ($18M) | — |
| Net Income | ($4M) | ($3M) | ($5M) | ($44M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($1M) | ($1M) | ($2M) | ($2M) | — |
| Net Income | ($3M) | ($1M) | ($1M) | ($0M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $10M | $13M | $18M | — |
| Total Liabilities | $1M | $1M | $2M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CYCN viewer.
About TickerBase · Data methodology & sources